Banner Portal
Histomorphometric study of alveolar bone after therapy with immunosuppressant FK506
PDF

Keywords

Tooth/immunology
Tooth movement
Bone and bones

How to Cite

1.
Santos RL dos, Souza MF de, Gonçalves RT, Martins MA, Souza MMG de. Histomorphometric study of alveolar bone after therapy with immunosuppressant FK506. Braz. J. Oral Sci. [Internet]. 2015 Dec. 17 [cited 2024 Apr. 13];8(1):19-24. Available from: https://periodicos.sbu.unicamp.br/ojs/index.php/bjos/article/view/8642323

Abstract

Aim: Several medications affect bone metabolism and the rate of tooth movement. The objective of the present study was to test the hypothesis that treatment with immunosuppressant tacrolimus (FK506) can interfere with bone turnover, decreasing the rate of tooth movement. Methods: Sixty male Wistar rats were divided into four groups of 15 animals each: Group 1: rats subjected to orthodontic movement plus treatment with saline solution vehicle; Group 2: rats subjected to orthodontic movement plus treatment with FK506; Group 3: rats treated with FK506 only; and Group 4: rats treated with saline solution vehicle only. The FK506 dose was 2 mg/kg/day. The treatment was initiated 14 days before the appliance installation and then kept for up to 14 days. In addition to the administration of the immunosuppressive drug, 10 mg/kg of oxytetracycline were injected at intervals of three days in order to show osteoblastic activity and bone growth at a histological level. Results: Histomorphometrical measurements showed greater tooth movement in Group 1 than in Group 2 at all periods (days 3, 7 and 14), though significant difference (p < 0.05) was observed only on days 7 and 14. Conclusions: FK506 significantly influenced the rate of tooth movement in rats subjected to the application of this medication.
https://doi.org/10.20396/bjos.v8i1.8642323
PDF

The Brazilian Journal of Oral Sciences uses the Creative Commons license (CC), thus preserving the integrity of the articles in an open access environment.

Downloads

Download data is not yet available.